Butyric Acid

Butyric Acid

SCHEMBL487253

CCCC(=O)O.ClCCl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL7952938 1.00 FFAR3 (0.81)
Butyric Acid SCHEMBL7947676 1.00 FFAR3 (0.81)
Butyric Acid SCHEMBL3090254 0.97 FFAR3 (0.77)
Butyric Acid SCHEMBL4902757 0.94 FFAR3 (0.72)
Butyric Acid SCHEMBL31510325 0.94
Butyric Acid SCHEMBL3554639 0.92 FFAR3 (0.68)
Butyric Acid SCHEMBL4884624 0.92 FFAR3 (0.68)
Butyric Acid SCHEMBL5655493 0.92 FFAR3 (0.68)
Butyric Acid SCHEMBL8169242 0.91 FFAR3 (0.77)
Butyric Acid SCHEMBL6535760 0.91 FFAR3 (0.77)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 477 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9133152-B2 Process for the purification 10-deacetylbaccatine III from 10-deacetyl-2-debenzoyl-2-pentenoylbaccatine III INDENA S.P.A. (IT) 2015-09-15 US claimed
EP-1885707-B1 A PROCESS FOR THE PURIFICATION OF 10-DEACETYLBACCATINE III FROM 10-DE ACET YL-2- DEBENZOYL-2-PENTENOYLBACCATINE III INDENA SPA (IT) 2011-02-23 EP claimed
US-20090298926-A1 PROCESS FOR THE PURIFICATION 10-DEACETYBACCATINE III FROM 10-DEACETYL-2-DEBENZOYL-2-PENTENOYLBACCATINE III INDENA S.P.A. (IT) 2009-12-03 US claimed
US-11939347-B2 1′-cyano nucleoside analogs and uses thereof GILEAD SCIENCES, INC. (US) 2024-03-26 US disclosed
US-20240082425-A1 LIPID STRUCTURES AND COMPOSITIONS COMPRISING SAME METHUSELAH FOUNDATION 2024-03-14 US disclosed
EP-4333898-A2 PEPTIDE-LIPID CONJUGATES Arcturus Therapeutics, Inc. (US) 2024-03-13 EP disclosed
EP-4334455-A1 LIPID COMPOSITIONS COMPRISING PEPTIDE-LIPID CONJUGATES Arcturus Therapeutics, Inc. (US) 2024-03-13 EP disclosed
EP-4329718-A1 TOPICAL COMPOSITIONS COMPRISING (GLYCO)SPHINGOLIPIDS AND/OR (GLYCO)CERAMIDES CARBOCODE S.A. (PT) 2024-03-06 EP disclosed
US-20240027346-A1 DETECTION METHOD THE UNIVERSITY OF QUEENSLAND (AU) 2024-01-25 US disclosed
WO-2023250197-A2 LIPID STRUCTURES AND COMPOSITIONS COMPRISING SAME TURN BIOTECHNOLOGIES, INC. (US) 2023-12-28 WO disclosed
US-11840531-B2 CDK8/19 inhibitors JOINT STOCK COMPANY "BIOCAD" (RU) 2023-12-12 US disclosed
EP-0022326-A1 Process for chemically removing the acyl sidechain from cephalosporins and penicillins E.R. Squibb &amp; Sons, Inc. (US) 1981-01-14 EP disclosed
EP-0009487-A1 NEW DERIVATES FROM BENZAMIDE. DEBIOPHARM SA (CH) 1980-04-16 EP disclosed
US-4182866-A CEPHALOSPORINS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1980-01-08 US disclosed
US-4180662-A ANTIINFLAMMATORY, ANALGESIC, ANTIRHEUMATIC, ANTITHROMBOTIC HOFFMANN-LA ROCHE INC. (US) 1979-12-25 US disclosed
US-4165326-A Steroids and their preparation ROUSSEL UCLAF (FR) 1979-08-21 US disclosed
WO-1979000517-A1 NEW DERIVATES FROM BENZAMIDE APPLIFARM SA (CH) 1979-08-09 WO disclosed
US-4072751-A INSECTICIDES, MITICIDES, NEMATOCIDES UNION CARBIDE CORPORATION (US) 1978-02-07 US disclosed
US-4041047-A ANTIASTHMATICS CIBA-GEIGY CORPORATION (US) 1977-08-09 US disclosed
US-3970670-A ANTIHISTAMINE CIBA-GEIGY CORPORATION (US) 1976-07-20 US disclosed